PHARMACY

Amerigen gets FDA nod for generic Adderall XR
Amerigen’s generic of Shire’s extended-release ADHD drug will be available in 5-, 10-, 15-, 20-, 25- and 30-mg dosage strengths.
Dr. Reddy’s launches generic Diprivan
Dr. Reddy's is offering generic Diprivan (propofol) injectable emulsion, which had a market value of roughly $310 million for the year ended November 2018, according to IQVIA data.

CVS Health's Accordant gets NCQA case management accreditation

Accordant, a CVS Health company, has received its second three-year accreditation for case management from NCQA, demonstrating compliance with the organization's case management program standards.
Easing open enrollment uncertainty for patients

AmerisourceBergen’s Kelly Gasper discusses how pharmacists can play an integral role in helping patients navigate open enrollment and the potential changes it brings.
Lannett launches 2 generics through recently inked deals

Lannett is launching generic Syprine and Comtan, which had a market value of $140 million, and $23 million, respectively.
Benzer Pharmacy names chief technology, marketing officer

Meghann Chilcott, formerly of OrderInsite, is joining Benzer Pharmacy as its chief technology and marketing officer.
Survey: Patients concerned about taking medication properly

Patients who lack confidence in taking medications properly blame it on a lack of time with physicians, according to a new survey from e-prescribing and medication management solutions company DrFirst.
HRG’s Rx Track-and-Trace tool targets DSCSA compliance

Hamacher's Rx Track-and-Trace Compliance Services include multiple components to help pharmacies meet Drug Supply Chain Security Act requirements.
Amneal taps Todd Branning as CFO

Todd Branning, formerly Teva’s CFO, has joined Amneal as senior vice president and CFO.
Slayback Pharma intros generic Makena

Slayback’s generic Makena also is the first generic of Amag Pharmaceuticals’ drug in a multidose vial.